Cross-talk between the T cell antigen receptor and the glucocorticoid receptor regulates thymocyte development

Stem Cells

Volumn 14, Issue 5, 1996, Pages 490-500

  Ashwell, Jonathan D ^a,c   King, Leslie B ^b   Vacchio, Melanie S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis; Glucocorticoid receptor; Glucocorticoids; Steroids; T cell receptor; Thymocyte development; Thymocyte selection

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LIGAND; STEROID; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; CELL MATURATION; CELL SELECTION; CELL SURVIVAL; CROSS LINKING; REVIEW; STEROIDOGENESIS; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0029744303     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140490     Document Type: Review

References (58)

1. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334:395-402.
2. Sprent J, Lo D, Gao E-K et al. T cell selection in the thymus. Immunol Rev 1988;101:172-190.
3. Shortman K, Egerton M, Spangrude GJ et al. The generation and fate of thymocytes. Semin Immunol 1990;2:3-12.
4. Huesmann M, Scott B, Kisielow P et al. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 1991;66:533-540.
5. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994;372:100-103.
6. Jaffe HL. The influence of the suprarenal gland on the thymus. III. Stimulation of the growth of the thymus gland following double supradrenalectomy in young rats. J Exp Med 1924;40:753-759.
7. Inomata T, Nakamura T. Influence of adrenalectomy on the development of the neonatal thymus in the rat. Biol Neonate 1989;55:238-243.
8. Sentman CL, Shutter JR, Hockenbery D et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991;67:879-888.
9. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-899.
10. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today 1994;15:362-366.
11. Hogquist KA, Jameson SC, Heath WR et al. T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17-27.
12. Sloan-Lancaster J, Shaw AS, Rothbard JB et al. Partial T cell signaling: altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-922.
13. Madrenas J, Wange RL, Wang JL et al. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995;267:515-518.
14. + thymocytes by T-cell receptor peptide antagonists. Proc Natl Acad Sci USA 1994;91:4057-4061.
15. Goodman HM. Basic Medical Endocrinology, Second Edition. New York: Raven Press, 1994.
16. LaPlante C, Giroud CJP, Stachenko J. Lack of appreciable 17α-hydroxylase activity in the normal and regenerated rat adrenal cortex. Endocrinology 1964;75:825-827.
17. Milgrom E. Steroid hormones. In: Baulieu E-E, Kelly PA, eds. Hormones: from Molecules to Disease. New York: Hermann Chapman and Hall, 1990:386-437.
18. Owens-Grillo JK, Hoffmann K, Hutchison KA et al. The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem 1995;270:20479-20484.
19. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83:851-857.
20. Zacharchuk CM, Ashwell JD. Fruitful outcomes of intracellular cross-talk. Curr Biol 1992;2:246-248.
21. Auphan N, Didonata JA, Rosette C et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-290.
22. Scheinman RI, Cogswell PC, Lofquist AK et al. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-286.
23. Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14:133-151.
24. Dieken ES, Miesfeld RL. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol 1992;12:589-597.
25. Thompson EB, Nazareth LV, Thulasi R et al. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis. J Steroid Biochem Mol Biol 1992;41:273-282.
26. Helmberg A, Auphan N, Caelles C et al. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995;14:452-460.
27. Hockenbery DM, Zutter M, Hickey W et al. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965.
28. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1994;1:197-205.
29. Siegel RM, Katsumata M, Miyashita T et al. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci USA 1992;89:7003-7007.
30. Nakayama K, Nakayama K, Negishi I et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993;261:1584-1588.
31. Ashwell JD, Cunningham RE, Noguchi PD et al. Cell growth cycle block of T cell hybridomas upon activation with antigen. J Exp Med 1987;165:173-194.
32. Mercep M, Bluestone JA, Noguchi PD et al. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J Immunol 1988;140:324-335.
33. Ucker DS, Ashwell JD, Nickas G. Activation driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol 1989;143:3461-3469.
34. Zacharchuk CM, Mercep M, Chakraborti P et al. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol 1990;145:4037-4045.
35. Yang Y, Mercep M, Ware CF et al. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 1995;181:1673-1682.
36. Zacharchuk CM, Mercep M, Ashwell JD. Thymocyte activation and death: a mechanism for molding the T cell repertoire. In: Edelson RL, ed. Antigen and Clone-Specific Immunoregulation. New York: Annals of the New York Academy of Science, 1991:52-70.
37. Iwata M, Hanaoka S, Sato K. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur J Immunol 1991;21:643-648.
38. Henning SJ. Plasma concentrations of total and free corticosterone during development in the rat. Am J Physiol 1978;235:E451-E456.
39. Savu L, Zouaghi H, Nunez EA. Serum inflammatory responses of transcortin binding activities and of total and free corticosterone and progesterone levels in developing rats: a kinetic approach. Int J Tissue React 1985;7:443-448.
40. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med 1994;179:1835-1846.
41. Arai M, Widmaier EP. Steroidogenesis in isolated adrenocortical cells during development in rats. Mol Cell Endocrinol 1993;92:91-107.
42. Cole TJ, Blendy JA, Monaghan AP et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-1621.
43. Garvin AM, Abraham KM, Forbush KA et al. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int Immunol 1990;2:173-180.
44. King LB, Vacchio MS, Dixon K et al. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 1995;3:647-656.
45. Pepin MC, Pothier F, Barden N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 1992;355:725-728.
46. Saint-Ruf C, Ungewiss K, Groettrup M et al. Analysis and expression of a cloned pre-T cell receptor gene. Science 1994;266:1208-1212.
47. Rothenberg EV. The development of functionally responsive T cells. Adv Immunol 1992;51:85-214.
48. lo thymocytes: expression of CD44. CD25 and early expression of TcRα mRNA. Eur J Immunol 1993;23:2109-2115.
49. Groettrup M, von Boehmer H. T cell receptor β chain dimers on immature thymocytes from normal mice. Eur J Immunol 1993;23:1393-1396.
50. van Oers NS, von Boehmer H, Weiss A. The pre-T cell receptor (TCR) complex is functionally coupled to the TCR-ζ subunit. J Exp Med 1995;182:1585-1590.
51. Mombaerts P, Anderson SJ, Perlmutter RM et al. An activated Ick transgene promotes thymocyte development in RAG-1 mutant mice. Immunity 1994;1:261-267.
52. Finkel TH, Cambier JC, Kubo RT et al. The thymus has two functionally distinct populations of immature αβ+ T cells: one population is deleted by ligation of αβ TCR. Cell 1989;58:1047-1054.
53. + thymocytes. Nature 1988;333:742-746.
54. Brunner T, Modil RJ, LaFace D et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444.
55. Ju S-T, Panka DJ, Cui H et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
56. Takahashi T, Tanaka M, Inazawa J et al. Human Fas ligand: gene structure, chromosomal location, and species specificity. Int Immunol 1994;6:1567-1574.
57. Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
58. Amakawa R, Hakem A, Kundig TM et al. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 1996;84:551-562.